TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
Tizona Therapeutics, Inc
Novartis
AstraZeneca
Genentech, Inc.
Columbia University
Astellas Pharma Inc
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Canadian Cancer Trials Group
Quadriga Biosciences, Inc.
Imperial College London
Syndax Pharmaceuticals
Weill Medical College of Cornell University
Novartis
Syndax Pharmaceuticals
Novartis
Celgene
National Institutes of Health Clinical Center (CC)
University of Chicago
National Institutes of Health Clinical Center (CC)
Celldex Therapeutics
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Northwestern University
Santa Maria Biotherapeutics
Memorial Sloan Kettering Cancer Center
Northwestern University
The Cleveland Clinic
Valerio Therapeutics
Valerio Therapeutics
Merck Sharp & Dohme LLC
Indiana University
University of Chicago
National Cancer Institute (NCI)
Altor BioScience
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Eisai Inc.
National Institutes of Health Clinical Center (CC)
Takeda
Pharmacyclics LLC.